198 related articles for article (PubMed ID: 16769552)
21. [Prognosis of pancreatic adenocarcinoma].
Escourrou J; Buscail L; Pages P; Moreau J; Faure P
Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C30-3. PubMed ID: 11787377
[No Abstract] [Full Text] [Related]
22. [Adjuvant and neoadjuvant treatment for pancreatic adenocarcinoma in 2006].
Deberne M; Huguet F; Le Scodan R; Hammel P; Andre T
Bull Cancer; 2007 Jan; 94(1):72-80. PubMed ID: 17237007
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant chemoradiation to convert locally advanced pancreatic body adenocarcinoma to resectable disease.
Cunningham SC; Cusnir M; Burdick RK; Van Echo DA; Moesinger R
Clin Adv Hematol Oncol; 2003 Dec; 1(12):741-2; discussion 743. PubMed ID: 16258479
[No Abstract] [Full Text] [Related]
24. Long-term effects of multimodal treatment for patients with resectable carcinoma of the pancreas.
Okabayashi T; Nishimori I; Nishioka A; Yamashita K; Sugimoto T; Dabanaka K; Maeda H; Kohsaki T; Ogawa Y; Kobayashi M; Onishi S; Hanazaki K
Oncol Rep; 2008 Sep; 20(3):651-6. PubMed ID: 18695919
[TBL] [Abstract][Full Text] [Related]
25. Gemcitabine following radiotherapy with concurrent 5-fluorouracil for nonmetastatic adenocarcinoma of the pancreas.
Kachnic LA; Shaw JE; Manning MA; Lauve AD; Neifeld JP
Int J Cancer; 2001 Apr; 96(2):132-9. PubMed ID: 11291097
[TBL] [Abstract][Full Text] [Related]
26. Systemic treatment of pancreatic cancer.
Van Cutsem E; Aerts R; Haustermans K; Topal B; Van Steenbergen W; Verslype C
Eur J Gastroenterol Hepatol; 2004 Mar; 16(3):265-74. PubMed ID: 15195889
[TBL] [Abstract][Full Text] [Related]
27. Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) model resistant to neoadjuvant chemotherapy (NAC).
Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
Pancreatology; 2015; 15(3):295-301. PubMed ID: 25800176
[TBL] [Abstract][Full Text] [Related]
28. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.
Showalter TN; Rao AS; Rani Anne P; Rosato FE; Rosato EL; Andrel J; Hyslop T; Xu X; Berger AC
Ann Surg Oncol; 2009 Aug; 16(8):2116-22. PubMed ID: 19437078
[TBL] [Abstract][Full Text] [Related]
29. Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma.
Landry J; Catalano PJ; Staley C; Harris W; Hoffman J; Talamonti M; Xu N; Cooper H; Benson AB
J Surg Oncol; 2010 Jun; 101(7):587-92. PubMed ID: 20461765
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study.
Van Laethem JL; Hammel P; Mornex F; Azria D; Van Tienhoven G; Vergauwe P; Peeters M; Polus M; Praet M; Mauer M; Collette L; Budach V; Lutz M; Van Cutsem E; Haustermans K
J Clin Oncol; 2010 Oct; 28(29):4450-6. PubMed ID: 20837948
[TBL] [Abstract][Full Text] [Related]
31. Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.
Ben-Josef E; Shields AF; Vaishampayan U; Vaitkevicius V; El-Rayes BF; McDermott P; Burmeister J; Bossenberger T; Philip PA
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):454-9. PubMed ID: 15145162
[TBL] [Abstract][Full Text] [Related]
32. Unresectable pancreatic adenocarcinoma treated with palladium-103 implant and chemoradiation.
Parikh S; Nori D
J Clin Gastroenterol; 1998 Mar; 26(2):158-60. PubMed ID: 9563935
[No Abstract] [Full Text] [Related]
33. Phase I trial of concurrent stereotactic body radiotherapy and nelfinavir for locally advanced borderline or unresectable pancreatic adenocarcinoma.
Lin C; Verma V; Ly QP; Lazenby A; Sasson A; Schwarz JK; Meza JL; Are C; Li S; Wang S; Hahn SM; Grem JL
Radiother Oncol; 2019 Mar; 132():55-62. PubMed ID: 30825970
[TBL] [Abstract][Full Text] [Related]
34. [Radiochemotherapy with gemcitabine and cisplatin in pancreatic cancer -- feasible and effective].
Wilkowski R; Thoma M; Heinemann V; Rau HG; Wagner A; Stoffregen C; Dühmke E
Strahlenther Onkol; 2003 Feb; 179(2):78-86. PubMed ID: 12590317
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic cancer: progress made.
Simianu VV; Zyromski NJ; Nakeeb A; Lillemoe KD
Acta Oncol; 2010 May; 49(4):407-17. PubMed ID: 20059311
[TBL] [Abstract][Full Text] [Related]
36. [A case of pancreatic cancer with local recurrence and liver metastases eight years after surgery].
Taniguchi H; Mizuma M; Motoi F; Abe T; Okada R; Kawaguchi K; Karasawa H; Masuda K; Yabuuchi S; Fukase K; Sakata N; Okada T; Nakagawa K; Hayashi H; Morikawa T; Yoshida H; Naito T; Katayose Y; Egawa S; Unno M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2193-5. PubMed ID: 25731467
[TBL] [Abstract][Full Text] [Related]
37. Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents.
Pisters PW; Hudec WA; Lee JE; Raijman I; Lahoti S; Janjan NA; Rich TA; Crane CH; Lenzi R; Wolff RA; Abbruzzese JL; Evans DB
J Clin Oncol; 2000 Feb; 18(4):860-7. PubMed ID: 10673529
[TBL] [Abstract][Full Text] [Related]
38. Complete pathological response following down-staging chemoradiation in locally advanced pancreatic cancer: challenging the boundaries.
Khan AZ; Pitsinis V; Mudan SS
World J Gastroenterol; 2007 Dec; 13(47):6433-5. PubMed ID: 18081235
[TBL] [Abstract][Full Text] [Related]
39. Resectable adenocarcinoma developing in the remnant pancreas 7 years after partial pancreatoduodenectomy for invasive ductal adenocarcinoma of the pancreas: a case report.
Frei L; Stieger R; Bayerl C; Breitenstein S; Staerkle RF
J Med Case Rep; 2017 Jul; 11(1):194. PubMed ID: 28716115
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer.
Maisonneuve P; Lowenfels AB
JAMA; 2007 Jun; 297(23):2581; author reply 2582. PubMed ID: 17579223
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
